In this issue:
Cariprazine vs risperidone for treatment of predominant negative symptoms in schizophrenia
Impaired identification of pleasant odours as a risk factor for transition of an ARMS to psychosis
Relapse risk following breaks in antipsychotic treatment of first episode psychosis
LAIs prescribing trends
Degree of cannabis use and cognitive impairment in psychosis
Schizophrenia-like phenotypes in mice with NMDA receptor ablation
Impaired glucose homeostasis in first-episode schizophrenia
Effect of ω-3 PUFAs in young people at ultrahigh risk for psychotic disorders
CVS improves insight into illness in schizophrenia
Critical treatment window of clozapine in treatment-resistant schizophrenia
Please login below to download this issue (PDF)